Olema Pharmaceuticals, Inc.
OLMA
$3.06
-$0.12-3.77%
| Weiss Ratings | OLMA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | OLMA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | OLMA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.30 | |||
| Price History | OLMA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -25.55% | |||
| 30-Day Total Return | -34.33% | |||
| 60-Day Total Return | -39.29% | |||
| 90-Day Total Return | -65.66% | |||
| Year to Date Total Return | -45.06% | |||
| 1-Year Total Return | -72.85% | |||
| 2-Year Total Return | -6.71% | |||
| 3-Year Total Return | -15.00% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -80.87% | |||
| 52-Week Low % Change | 11.19% | |||
| Price | OLMA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $16.62 | |||
| 52-Week Low Price | $2.86 | |||
| 52-Week Low Price (Date) | Apr 07, 2025 | |||
| 52-Week High Price (Date) | Aug 01, 2024 | |||
| Valuation | OLMA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 217.30M | |||
| Enterprise Value | -215.36M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -2.21 | |||
| Earnings Per Share Growth | 2.29% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.58 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $3.06 | |||
| Enterprise Value/EBITDA (TTM) | 1.52 | |||
| Enterprise Value/EBIT | 1.51 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | OLMA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 65.79M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | OLMA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 415 651 3316 | |||
| Address | 780 Brannan Street San Francisco, CA 94103 | |||
| Website | olema.com | |||
| Country | United States | |||
| Year Founded | 2006 | |||
| Profitability | OLMA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | OLMA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -24.43% | |||
| Return on Equity | -- | |||
| Income Statement | OLMA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -141.87M | |||
| EBIT (TTM) | -142.26M | |||
| Net Income (TTM) | -129.47M | |||
| Net Income Avl. to Common (TTM) | -129.47M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -25.38% | |||
| EPS Diluted (TTM) | -2.21 | |||
| EPS Diluted Growth (Q YOY) | -4.40% | |||
| Balance Sheet | OLMA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 434.09M | |||
| Cash Per Share (Q) | $6.60 | |||
| Total Current Assets (Q) | 438.47M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 408.96M | |||
| Current Ratio (Q) | 10.500 | |||
| Book Value Per Share (Q) | $5.50 | |||
| Total Assets (Q) | 450.98M | |||
| Total Current Liabilities (Q) | 41.76M | |||
| Total Debt (Q) | 1.43M | |||
| Total Liabilities (Q) | 42.02M | |||
| Total Common Equity (Q) | 408.96M | |||
| Cash Flow | OLMA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -93.53M | |||
| Cash from Financing (TTM) | 268.82M | |||
| Net Change in Cash (TTM) | 70.94M | |||
| Levered Free Cash Flow (TTM) | -45.82M | |||
| Cash from Operations (TTM) | -104.35M | |||
